Comparative Evaluation of Preoperative Preparation Methods in Patients With Large Incisional Hernias
ClinicalTrials.gov Studies
Summary
NIH has registered a new comparative clinical study (NCT07549113) evaluating preoperative preparation methods for patients with large incisional hernias. The study will compare four approaches: botulinum toxin A injection, progressive preoperative pneumoperitoneum, combined preparation, and standard preoperative management. The trial will assess operative feasibility, ability to achieve fascial closure, postoperative complications, recurrence rates, and overall treatment outcomes across approximately 400 participants at a single US site.
“This study aims to compare the effectiveness and safety of different preoperative preparation strategies in patients with large postoperative ventral hernias and loss of abdominal wall domain.”
About this source
ClinicalTrials.gov is the NIH-run registry of every clinical trial conducted in the United States, plus most international trials sponsored by US-based companies or institutions. By federal law, sponsors must register Phase 2 through Phase 4 studies before enrolling patients and post results within a year of completion. This feed tracks every new trial registration and study update, around 700 a month: drug interventions, device studies, behavioral protocols, observational research. Watch this if you scout drug candidates moving into mid or late-stage development, monitor competitor pipelines, or follow rare disease research where new trials signal patient hope. GovPing parses sponsor, phase, intervention, and target indication on each entry.
What changed
NIH registered a new comparative effectiveness study on ClinicalTrials.gov examining preoperative optimization strategies for large incisional hernia repair. The trial will enroll patients receiving one of four preparation approaches: botulinum toxin A injection, progressive preoperative pneumoperitoneum, combined preparation, or standard management. Primary endpoints include operative feasibility, fascial closure rates, postoperative complications, and hernia recurrence.
Healthcare providers and clinical investigators involved in abdominal wall reconstruction should be aware of this upcoming evidence on comparative preparation methods. The study results may inform future clinical practice guidelines for preoperative optimization of complex ventral hernia patients.
Archived snapshot
Apr 23, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Comparative Evaluation of Preoperative Preparation Methods in Patients With Large Incisional Hernias
N/A NCT07549113 Kind: NA Apr 23, 2026
Abstract
Patients with large, complex, or giant incisional hernias often require advanced preoperative optimization to facilitate safe abdominal wall reconstruction and reduce postoperative complications. Several strategies are currently used in clinical practice, including botulinum toxin A injection, progressive preoperative pneumoperitoneum, and their combination. However, the optimal differentiated approach based on hernia characteristics and abdominal wall tissue deficiency remains unclear.
This study aims to compare the effectiveness and safety of different preoperative preparation strategies in patients with large postoperative ventral hernias and loss of abdominal wall domain. Outcomes of patients receiving botulinum toxin A, progressive preoperative pneumoperitoneum, combined preparation, or no specific preparation will be analyzed.
The study will evaluate operative feasibility, ability to achieve fascial closure, postoperative complications, recurrence, and overall treatment outcomes.
Conditions: Incisional Hernia Repair, Ventral Hernia Repair
Interventions: Botulinum Toxin A (Botox ), Progressive Preoperative Pneumoperitoneum, Combined Preoperative Preparation, Standard Preoperative Management
Related changes
Get daily alerts for ClinicalTrials.gov Studies
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from NIH.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when ClinicalTrials.gov Studies publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.